Related content

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

By Djavan B.   Zlotta A.   Kratzik C.   Remzi M.   Seitz C.   Schulman C.C.   Marberger M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study

By Kaplan S.A.   Ghafar M.A.   Volpe M.A.   Lam J.S.   Fromer D.   Te A.E.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 464-468

Elsevier

Access to resources Recommend Favorite

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2–10 ng/ml in 4,480 men

By Stephan Carsten   Xu Chuanliang   Cammann Henning   Graefen Markus   Haese Alexander   Huland Hartwig   Semjonow Axel   Diamandis Eleftherios   Remzi Mesut   Djavan Bob   Wildhagen Mark   Blijenberg Bert   Finne Patrik   Stenman Ulf-Hakan   Jung Klaus   Meyer Hellmuth-Alexander  

World Journal of Urology, Vol. 25, Iss. 1, 2007-03 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis

By Sokoll L.J.   Chan D.W.   Mikolajczyk S.D.   Rittenhouse H.G.   Evans C.L.   Linton H.J.   Mangold L.A.   Mohr P.   Bartsch G.   Klocker H.   Horninger W.   Partin A.W.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 274-276

Elsevier

Access to resources Recommend Favorite